The SP142 rabbit antibody IHC assay was used to assess PD-L1 status in archival specimens as discussed above; PD-L1 positivity was defined as ≥10% PD-L1 positive immune cells in the tumor microenvironment (defined as 3+ in the phase I study of atezolizumab). Here, CD274 is linked to neoplasm.